Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation
Platelet activation has been reported to play a major role in arterial thrombosis, cancer metastasis, and progression. Recently, we developed a novel Ir(III)-based compound, [Ir(Cp∗)1-(2-pyridyl)-3-(4-dimethylaminophenyl)imidazo[1,5-a]pyridine Cl]BF4 or Ir-6 and assessed its effectiveness as an anti...
Saved in:
Main Authors: | Ren-Shi Shyu, Themmila Khamrang, Joen-Rong Sheu, Chih-Wei Hsia, Marappan Velusamy, Chih-Hsuan Hsia, Duen-Suey Chou, Chao-Chien Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Bioinorganic Chemistry and Applications |
Online Access: | http://dx.doi.org/10.1155/2018/8291393 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovative Targeting Strategies in Drug Therapy for Inflammatory Diseases: Mechanistic Approaches
by: Duen-Suey Chou, et al.
Published: (2015-01-01) -
Effect of Antrodia camphorata on Inflammatory Arterial Thrombosis-Mediated Platelet Activation: The Pivotal Role of Protein Kinase C
by: Wan-Jung Lu, et al.
Published: (2014-01-01) -
Synthesis of Water-Soluble Iridium (III)-Containing Nanoparticles for Biological Applications
by: Huanzhi Hou, et al.
Published: (2015-01-01) -
Asymmetric synthesis of stereogenic-at-iridium(III) complexes through Pd-catalyzed kinetic resolution
by: Yun-Peng Chu, et al.
Published: (2025-01-01) -
Review of Atypical Organometallic Compounds as Antimalarial Drugs
by: Samuel K. Kwofie, et al.
Published: (2020-01-01)